With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping the operation overseas.

Baron Funds mentioned Eli Lilly and Company (NYSE:LLY) in its Q2 2024 investor letter. Here is what the fund said: ...

Eli Lilly unveiled its new $800m (€726m) facility expansion in Kinsale, Co Cork, which began making medicines last year to ...

Nearly $1 billion will go toward expanding a facility that last year began making medicines for the company's new diabetes and obesity treatments.

Demand for Eli Lilly’s Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily ...

The financial leadership transition is coming as the pharma giant hovers just below a $1 trillion market cap in the midst of rising demand for several new medications.

Eli Lilly and Company has promoted ... Ashkenazi served as CFO for several of the company’s global business areas. “One piece of advice I give new hires or people starting their career is ...

Eli Lilly and Company’s LLY stock has risen 21.1% in ... In the past couple of years, it has received approvals for several new drugs like Kisunla, Omvoh and Jaypirca and witnessed pipeline ...

Eli Lilly has again upped the ante in scaling up its manufacturing footprint, this time revealing an investment totaling $1.8 billion to expand production capacity at two plants in Ireland. | Eli ...